178 related articles for article (PubMed ID: 24039769)
1. A cell-permeable fusion protein based on Clostridium botulinum C2 toxin for delivery of p53 tumorsuppressor into cancer cells.
Fahrer J; Rausch J; Barth H
PLoS One; 2013; 8(9):e72455. PubMed ID: 24039769
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered clostridial C2 toxin as a novel delivery system for living mammalian cells.
Fahrer J; Plunien R; Binder U; Langer T; Seliger H; Barth H
Bioconjug Chem; 2010 Jan; 21(1):130-9. PubMed ID: 20030334
[TBL] [Abstract][Full Text] [Related]
3. Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.
Fahrer J; Funk J; Lillich M; Barth H
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):263-73. PubMed ID: 21136248
[TBL] [Abstract][Full Text] [Related]
4. The binary Clostridium botulinum C2 toxin as a protein delivery system: identification of the minimal protein region necessary for interaction of toxin components.
Barth H; Roebling R; Fritz M; Aktories K
J Biol Chem; 2002 Feb; 277(7):5074-81. PubMed ID: 11741886
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake of Clostridium botulinum C2 toxin: membrane translocation of a fusion toxin requires unfolding of its dihydrofolate reductase domain.
Haug G; Wilde C; Leemhuis J; Meyer DK; Aktories K; Barth H
Biochemistry; 2003 Dec; 42(51):15284-91. PubMed ID: 14690438
[TBL] [Abstract][Full Text] [Related]
6. A cell-permeable fusion toxin as a tool to study the consequences of actin-ADP-ribosylation caused by the salmonella enterica virulence factor SpvB in intact cells.
Pust S; Hochmann H; Kaiser E; von Figura G; Heine K; Aktories K; Barth H
J Biol Chem; 2007 Apr; 282(14):10272-82. PubMed ID: 17283073
[TBL] [Abstract][Full Text] [Related]
7. Purification and activity of the Rho ADP-ribosylating binary C2/C3 toxin.
Haug G; Barth H; Aktories K
Methods Enzymol; 2006; 406():117-27. PubMed ID: 16472654
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin.
Barth H; Hofmann F; Olenik C; Just I; Aktories K
Infect Immun; 1998 Apr; 66(4):1364-9. PubMed ID: 9529054
[TBL] [Abstract][Full Text] [Related]
9. C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein p53 into tumor cells.
Fahrer J; Schweitzer B; Fiedler K; Langer T; Gierschik P; Barth H
Bioconjug Chem; 2013 Apr; 24(4):595-603. PubMed ID: 23506195
[TBL] [Abstract][Full Text] [Related]
10. The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol.
Haug G; Leemhuis J; Tiemann D; Meyer DK; Aktories K; Barth H
J Biol Chem; 2003 Aug; 278(34):32266-74. PubMed ID: 12805360
[TBL] [Abstract][Full Text] [Related]
11. Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol.
Pavlik BJ; Hruska EJ; Van Cott KE; Blum PH
Sci Rep; 2016 Mar; 6():23707. PubMed ID: 27025362
[TBL] [Abstract][Full Text] [Related]
12. Intracellular trafficking of Clostridium botulinum C2 toxin.
Nagahama M; Takahashi C; Aoyanagi K; Tashiro R; Kobayashi K; Sakaguchi Y; Ishidoh K; Sakurai J
Toxicon; 2014 May; 82():76-82. PubMed ID: 24582943
[TBL] [Abstract][Full Text] [Related]
13. FK506-binding protein 51 interacts with Clostridium botulinum C2 toxin and FK506 inhibits membrane translocation of the toxin in mammalian cells.
Kaiser E; Böhm N; Ernst K; Langer S; Schwan C; Aktories K; Popoff M; Fischer G; Barth H
Cell Microbiol; 2012 Aug; 14(8):1193-205. PubMed ID: 22420783
[TBL] [Abstract][Full Text] [Related]
14. Clostridium botulinum C2 toxin: low pH-induced pore formation is required for translocation of the enzyme component C2I into the cytosol of host cells.
Blöcker D; Pohlmann K; Haug G; Bachmeyer C; Benz R; Aktories K; Barth H
J Biol Chem; 2003 Sep; 278(39):37360-7. PubMed ID: 12869543
[TBL] [Abstract][Full Text] [Related]
15. Inhibitions of the translocation pore of Clostridium botulinum C2 toxin by tailored azolopyridinium salts protects human cells from intoxication.
Bronnhuber A; Maier E; Riedl Z; Hajós G; Benz R; Barth H
Toxicology; 2014 Feb; 316():25-33. PubMed ID: 24394545
[TBL] [Abstract][Full Text] [Related]
16. Rho-inhibiting C2IN-C3 fusion toxin inhibits chemotactic recruitment of human monocytes ex vivo and in mice in vivo.
Martin T; Möglich A; Felix I; Förtsch C; Rittlinger A; Palmer A; Denk S; Schneider J; Notbohm L; Vogel M; Geiger H; Paschke S; Huber-Lang M; Barth H
Arch Toxicol; 2018 Jan; 92(1):323-336. PubMed ID: 28924833
[TBL] [Abstract][Full Text] [Related]
17. Formation of a biologically active toxin complex of the binary Clostridium botulinum C2 toxin without cell membrane interaction.
Kaiser E; Haug G; Hliscs M; Aktories K; Barth H
Biochemistry; 2006 Nov; 45(44):13361-8. PubMed ID: 17073457
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine derivatives block the translocation pores and inhibit cellular entry of Clostridium botulinum C2 toxin and Bacillus anthracis lethal toxin.
Kreidler AM; Benz R; Barth H
Arch Toxicol; 2017 Mar; 91(3):1431-1445. PubMed ID: 27106023
[TBL] [Abstract][Full Text] [Related]
19. Binding and internalization of Clostridium botulinum C2 toxin.
Nagahama M; Hagiyama T; Kojima T; Aoyanagi K; Takahashi C; Oda M; Sakaguchi Y; Oguma K; Sakurai J
Infect Immun; 2009 Nov; 77(11):5139-48. PubMed ID: 19720757
[TBL] [Abstract][Full Text] [Related]
20. Cyclophilin A facilitates translocation of the Clostridium botulinum C2 toxin across membranes of acidified endosomes into the cytosol of mammalian cells.
Kaiser E; Pust S; Kroll C; Barth H
Cell Microbiol; 2009 May; 11(5):780-95. PubMed ID: 19159389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
